...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith Capital Corp. to Present on the Emerging Growth Conference on September 25, 2024

+ it there ever happens to be any truth to the BS being spread we would see a spike in one or both plays regardless of how corrupt the so called OTC expert market is. How the heck did they come up with the "expert" part - experts on manipulating stock pricing?

I would expect a bump on RVX as well so maybe the TSX will give us our first & best hint .....

My belief is, will be saying the same things that have been repeatedly said about this ceo & management team as we approach the rvx agm next year - listening to the master of disasters BS all over again. Given the dismal record over 2 decades & especially the last 5 years it would be hard to bet otherwise imo.

Share
New Message
Please login to post a reply